(Q39619684)

13 September 2017

title

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer (English)

1 reference

13 September 2017

Juan Zhang

1

1 reference

13 September 2017

Jie Sun

2

1 reference

13 September 2017

Jiuan Chen

3

1 reference

13 September 2017

Lu Yao

4

1 reference

13 September 2017

Tao Ouyang

5

1 reference

13 September 2017

Jinfeng Li

6

1 reference

13 September 2017

Tianfeng Wang

7

1 reference

13 September 2017

Zhaoqing Fan

8

1 reference

13 September 2017

Tie Fan

9

1 reference

13 September 2017

Benyao Lin

10

1 reference

13 September 2017

Yuntao Xie

11

1 reference

13 September 2017

language of work or name

English

0 references

publication date

8 July 2016

1 reference

Breast Cancer Research and Treatment

13 September 2017

published in

1 reference

13 September 2017

volume

158

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

455-462

1 reference

13 September 2017

cites work

Breast cancer in China

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Classification of BRCA1 missense variants of unknown clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

BRCA1 and BRCA2 mutations in women from Shanghai China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Performance of BRCA1/2 mutation prediction models in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

BRCA-associated breast cancer in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

BRCA1 and BRCA2: 1994 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3902-0

10.1007/S10549-016-3902-0

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference